Compuen (CGEN) Ukubelenga kwa Stock
Cipimo ca AI : CGEN
AI ileposa chilango ca nshita ya kucila ku bushiku bumo bwa kucita malishiti, ku mpela ya mulungu na ku mpela ya mweshi. Ukukula kulapimwa ukutula ku nshita ya kucila. Aya ni makani ya statistics, te malangililo ya kubika ndalama.
Ipimo mu nshiku 6 ishacita
Premium ilasanga ifyo AI ilatasha ukucita pa 1 day, 1 week na 1 month pa stock iyi na pa stock shonse shimbi.
Fungula Premium🔒 Ukukwata kwa ifipimo
Umulandu wa forecast — bonse ba kale pamo na nshita ya kucila — ni cipande ca Premium.
Fungula PremiumPa Kampani Ici
Compugen Ltd. is engaged in the research, development, and distribution of targeted and therapeutic drugs. The company’s portfolio primarily consists of early-stage and preclinical immuno-oncology programs aimed at developing cancer immunotherapies, both as monotherapies and in combination with other drugs. The company is also developing treatments for autoimmune diseases.
